Claims for Patent: 9,737,561
✉ Email this page to a colleague
Summary for Patent: 9,737,561
| Title: | Topical gels and methods of using the same |
| Abstract: | Provided according to some embodiments of the invention are topical gels that may release nitric oxide. Also provided are methods of using such topical gels in the treatment of wounds and other skin ailments. |
| Inventor(s): | Nathan Stasko, Susanne Bauman, Pranav R. Joshi |
| Assignee: | Lnhc Inc |
| Application Number: | US15/353,301 |
| Patent Claims: |
1. A method of treating a skin ailment in a subject, the method comprising: administering to a subject a topical composition comprising nitric oxide-releasing polysiloxane macromolecules and a hydrophobic, non-aqueous gel base, the hydrophobic, non-aqueous gel base comprising mineral oil, wherein the nitric oxide (NO) storage per gram is in a range of 100 nmol NO/g to 1 mmol NO/g of the topical composition and at least 70% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature. 2. The method of claim 1, wherein the nitric oxide-releasing polysiloxane macromolecules are diazeniumdiolate-functionalized polysiloxane macromolecules. 3. The method of claim 1, wherein the method decreases inflammation in the subject. 4. The method of claim 1, wherein the method decreases inflammatory response factors in the subject. 5. The method of claim 1, wherein the method modulates inflammatory cytokines in the subject. 6. The method of claim 1, wherein the skin ailment is an inflammatory skin condition. 7. The method of claim 1, wherein the skin ailment is impetigo, psoriasis, tinea pedis, or onychomycosis. 8. The method of claim 1, wherein the topical composition is antimicrobial. 9. The method of claim 1, wherein the topical composition disperses a biofilm. 10. The method of claim 1, wherein the topical composition disrupts the structure of the biofilm and/or prevents biofilm formation. 11. The method of claim 1, wherein the topical composition kills bacteria present in a biofilm. 12. A method of treating a skin ailment in a subject, the method comprising: administering to a subject a topical composition comprising nitric oxide-releasing polysiloxane macromolecules and a hydrophilic gel base, the hydrophilic gel base comprising an alcohol, wherein the nitric oxide (NO) storage per gram is in a range of 100 nmol NO/g to 1 mmol NO/g of the topical composition and at least 70% of NO of the nitric oxide-releasing polysiloxane macromolecule remains in the topical composition two days after initial formulation when the topical composition is stored at room temperature. 13. The method of claim 12, wherein the nitric oxide-releasing polysiloxane macromolecules are diazeniumdiolate-functionalized polysiloxane macromolecules. 14. The method of claim 12, wherein the method decreases inflammation in the subject. 15. The method of claim 12, wherein the method decreases inflammatory response factors in the subject. 16. The method of claim 12, wherein the method modulates inflammatory cytokines in the subject. 17. The method of claim 12, wherein the skin ailment is an inflammatory skin condition. 18. The method of claim 12, wherein the skin ailment is impetigo, psoriasis, tinea pedis, or onychomycosis. 19. The method of claim 12, wherein the topical composition is antimicrobial. 20. The method of claim 12, wherein the topical composition disperses a biofilm. 21. The method of claim 12, wherein the topical composition disrupts the structure of the biofilm and/or prevents biofilm formation. 22. The method of claim 12, wherein the topical composition kills bacteria present in a biofilm. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
